Burney Co. Sells 9,555 Shares of Humana Inc. $HUM

Burney Co. lessened its position in shares of Humana Inc. (NYSE:HUM) by 75.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,175 shares of the insurance provider’s stock after selling 9,555 shares during the period. Burney Co.’s holdings in Humana were worth $826,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Revolve Wealth Partners LLC bought a new position in Humana during the fourth quarter worth about $202,000. State of Wyoming boosted its holdings in Humana by 10.1% in the 1st quarter. State of Wyoming now owns 850 shares of the insurance provider’s stock worth $225,000 after buying an additional 78 shares during the period. Canada Pension Plan Investment Board grew its stake in Humana by 41.4% in the 1st quarter. Canada Pension Plan Investment Board now owns 266,979 shares of the insurance provider’s stock valued at $70,643,000 after buying an additional 78,126 shares in the last quarter. Vident Advisory LLC raised its holdings in Humana by 42.2% during the 1st quarter. Vident Advisory LLC now owns 2,456 shares of the insurance provider’s stock valued at $650,000 after acquiring an additional 729 shares during the period. Finally, Quarry LP bought a new stake in Humana during the 1st quarter valued at $205,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of HUM opened at $258.71 on Monday. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The company has a market cap of $31.12 billion, a PE ratio of 24.25, a price-to-earnings-growth ratio of 1.51 and a beta of 0.46. The stock has a 50-day moving average price of $258.57 and a 200-day moving average price of $260.57.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The business had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same period last year, the firm posted $4.16 earnings per share. Humana’s quarterly revenue was up 11.1% on a year-over-year basis. As a group, equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a $0.885 dividend. The ex-dividend date is Friday, December 26th. This represents a $3.54 annualized dividend and a yield of 1.4%. Humana’s payout ratio is 33.18%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HUM. Wolfe Research cut their price target on Humana from $313.00 to $300.00 and set an “outperform” rating for the company in a report on Thursday, November 20th. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Wells Fargo & Company lifted their target price on Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Robert W. Baird lowered their price target on shares of Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a report on Thursday, December 11th. Finally, Barclays reduced their price objective on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 25th. Nine investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $294.32.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.